C&G Editor in Chief, Erin Harris
-
ISCT 2024 With Dr. Bruce Levine
5/23/2024
Here are highlights, quotes, and more from Episode 76 of Cell & Gene: The Podcast featuring Dr. Bruce Levine.
-
Is A One-Time Cure for HIV on the Horizon?
5/14/2024
Addimmune's CMO, Dr. Marcus Conant, shares information about the company's lead asset, AGT103-T, which has been designed to provide a functional cure for HIV.
-
Cell & Gene: The Podcast Post-Episode Recap: BlueRock Therapeutics' Dr. Ahmed Enayetallah
4/30/2024
This article shares highlights from Cell & Gene: The Podcast featuring BlueRock Therapeutics’ Dr. Ahmed Enayetallah. Heshares impressive data from the Phase 1 study to treat Parkinson's disease.
-
Cell & Gene: The Podcast Post-Episode Recap: Vor Bio's Dr. Robert Ang
4/26/2024
Welcome to my new article series, Cell & Gene: The Podcast Post-Episode Recap, which shares highlights, quotes, and more from recently aired episodes of Cell & Gene: The Podcast.
-
2024: The Year of Development in Cell Therapy
4/10/2024
We break down three trends driving development in cell therapy in 2024.
-
Nanoscope Therapeutics Tackling Vision Loss With Ocular Gene Therapy
3/27/2024
Leaders from Nanoscope Therapeutics explain the safety and efficacy data from as well as next steps for the company's RESTORE trial.
-
ICYMI: Q1 2024's Cell & Gene Live And Cell & Gene: The Podcast
3/27/2024
With Q1 of 2024 coming to close, I wanted to take this opportunity to make sure you’ve read, heard, or viewed some of insightful content we’ve created for Cell & Gene's readers since the start of the year.
-
Inside Tenaya Therapeutics' AAV9-Based Gene Therapy
3/27/2024
Tenaya Therapeutics' CSO explains how the company's gene therapy, TN-401, may treat heart disease.
-
Rare Disease Day 2024
2/29/2024
Today is Rare Disease Day 2024, a global initiative to raise awareness and generate support for everyone who is on a rare medical journey.
-
Video Clips From Cell & Gene Live: 2024 Regulatory Outlook With FDA's Dr. Peter Marks And Dr. Nicole Verdun
2/27/2024
Our recent Cell & Gene Live, 2024 Regulatory Outlook With FDA's Drs. Peter Marks and Nicole Verdun, was a chock full of data and valuable information. I've broken down the full-length presentation into bite sized video clips that you can view at your convenience.